ArticlebioRxiv : the preprint server for biology2025
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2.
Rahul K Suryawanshi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it